The burgeoning popularity of semaglutide , initially for metabolic conditions, is creating significant buzz within the UK , prompting a notable shift in medication trends. Access these treatments remains a complex situation , with public healthcare system coverage currently limited and specialist practices offering prescriptions at a substantial pr